Indian Immunologicals Limited-Product Pipeline Review-2015

Indian Immunologicals Limited-Product Pipeline Review-2015

  • Products Id :- GMDHC06913CDB
  • |
  • Pages: 29
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Indian Immunologicals Limited-Product Pipeline Review-2015


Global Markets Direct's, 'Indian Immunologicals Limited-Product Pipeline Review-2015', provides an overview of the Indian Immunologicals Limited's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Indian Immunologicals Limited's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Indian Immunologicals Limited including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Indian Immunologicals Limited's human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Indian Immunologicals Limited's pipeline products

Reasons To Buy

Evaluate Indian Immunologicals Limited's strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Indian Immunologicals Limited in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Indian Immunologicals Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Indian Immunologicals Limited and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Indian Immunologicals Limited

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Indian Immunologicals Limited and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Indian Immunologicals Limited Snapshot 5

Indian Immunologicals Limited Overview 5

Key Information 5

Key Facts 5

Indian Immunologicals Limited-Research and Development Overview 6

Key Therapeutic Areas 6

Indian Immunologicals Limited-Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products-Monotherapy 9

Pipeline Products-Combination Treatment Modalities 10

Indian Immunologicals Limited-Pipeline Products Glance 11

Indian Immunologicals Limited-Early Stage Pipeline Products 11

Preclinical Products/Combination Treatment Modalities 11

Indian Immunologicals Limited-Unknown Stage Pipeline Products 12

Unknown Products/Combination Treatment Modalities 12

Indian Immunologicals Limited-Drug Profiles 13

diphtheria + pertussis + tetanus + hepatitis B + haemophilus influenza [serotype B] vaccine 13

Product Description 13

Mechanism of Action 13

R&D Progress 13

haemophilus influenzae vaccine [type B] 14

Product Description 14

Mechanism of Action 14

R&D Progress 14

human papilloma virus vaccine [types 16 and 18] 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

alphavirus vaccine 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

chikungunya vaccine 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

flavivirus vaccine 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

Japanese encephalitis vaccine 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

picornavirus vaccine 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

vaccine for cervical cancer 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

Vaccine for Undisclosed Indication 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

Indian Immunologicals Limited-Pipeline Analysis 23

Indian Immunologicals Limited-Pipeline Products by Route of Administration 23

Indian Immunologicals Limited-Pipeline Products by Molecule Type 24

Indian Immunologicals Limited-Dormant Projects 25

Indian Immunologicals Limited-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Appendix 28

Methodology 28

Coverage 28

Secondary Research 28

Primary Research 28

Expert Panel Validation 28

Contact Us 28

Disclaimer 29

List of Tables

Indian Immunologicals Limited, Key Information 5

Indian Immunologicals Limited, Key Facts 5

Indian Immunologicals Limited-Pipeline by Indication, 2015 7

Indian Immunologicals Limited-Pipeline by Stage of Development, 2015 8

Indian Immunologicals Limited-Monotherapy Products in Pipeline, 2015 9

Indian Immunologicals Limited-Combination Treatment Modalities in Pipeline, 2015 10

Indian Immunologicals Limited-Preclinical, 2015 11

Indian Immunologicals Limited-Unknown, 2015 12

Indian Immunologicals Limited-Pipeline by Route of Administration, 2015 23

Indian Immunologicals Limited-Pipeline by Molecule Type, 2015 24

Indian Immunologicals Limited-Dormant Developmental Projects,2015 25

Indian Immunologicals Limited, Other Locations 26

List of Figures

Indian Immunologicals Limited-Pipeline by Top 10 Indication, 2015 7

Indian Immunologicals Limited-Pipeline by Stage of Development, 2015 8

Indian Immunologicals Limited-Monotherapy Products in Pipeline, 2015 9

Indian Immunologicals Limited-Pipeline by Top 10 Route of Administration, 2015 23

Indian Immunologicals Limited-Pipeline by Top 10 Molecule Type, 2015 24

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@]

Current R&D Portfolio of Indian Immunologicals Limited; Indian Immunologicals Limited - Key Therapeutics; Indian Immunologicals Limited - Pipeline Overview and Promising Molecules; Indian Immunologicals Limited - News; Indian Immunologicals Limited - Latest Updates; Indian Immunologicals Limited - Pipeline; Indian Immunologicals Limited - Discontinued/Dormant Projects

select a license

Single User License
USD 1500 INR 95760
Site License
USD 3000 INR 191520
Corporate User License
USD 4500 INR 287280



The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...

Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

query [@]